Stamford, CT -- (SBWIRE) -- 01/18/2014 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO), American Lorain Corporation(NYSEMKT:ALN), CytRx Corporation(NASDAQ:CYTR), DURECT Corporation(NASDAQ:DRRX)
AVEO Pharmaceuticals, Inc.(NASDAQ:AVEO) opened the session at $2.03, remained amid the day range of $1.98 - $2.07, and closed the session at $2.00. The stock showed a negative performance of -0.50% in previous trading session. The stock gained a volume of 1.48 million shares and the average volume of the stock remained 781,154.00 shares. AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, operates as a cancer therapeutics company. The company engages in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform.
Will AVEO Get Buyers Even After The Recent Rally? Find Out Here
American Lorain Corporation(NYSEMKT:ALN) traded with volume of 1.48 million shares in the prior session and the average volume of the stock remained 227,649.00 shares. The 52 week range of the stock remained $0.61 - $1.39. The stock showed a positive movement of +8.99% and closed its session at $0.970. The market capitalization of the stock remained 33.58 million. American Lorain Corporation engages in the development, manufacture, and sale of various food products. It provides chestnut products, including aerated open-bottom chestnuts, sweetheart chestnuts, chestnuts in syrup, and golden chestnut kernels.
Will ALN Continue To Move Higher? Find Out Here
CytRx Corporation(NASDAQ:CYTR) exchanged 1.47 million shares and the average volume remained 6.25 million shares. The stock escalated +1.00% and closed the session at $7.04. The beta of the stock remained 1.33 and the EPS of the stock remained -0.53. The shares outstanding of the stock remained 41.98 million. CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. Its oncology pipeline includes two programs, aldoxorubicin and tamibarotene, which are in clinical development for cancer indications.
For How Long CYTR will fight for Profitability? Read This Trend Analysis report
DURECT Corporation(NASDAQ:DRRX) gained volume of 1.45 million shares, while the average volume remained 935,006.00 shares. The stock decreased -5.07% and finished the session Friday at $2.06. The EPS of the stock remained -0.22. The one month of the stock was 34.64% and three month trend remained positive 45.07%. DURECT Corporation, a specialty pharmaceutical company, develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms.
Has DRRX Found The Bottom and Ready To Move Up? Find Out Here
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)